Correlation Between Eliem Therapeutics and Evaxion Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Evaxion Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Evaxion Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Evaxion Biotech AS, you can compare the effects of market volatilities on Eliem Therapeutics and Evaxion Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Evaxion Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Evaxion Biotech.

Diversification Opportunities for Eliem Therapeutics and Evaxion Biotech

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Eliem and Evaxion is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Evaxion Biotech AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evaxion Biotech AS and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Evaxion Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evaxion Biotech AS has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Evaxion Biotech go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Evaxion Biotech

Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.75 times more return on investment than Evaxion Biotech. However, Eliem Therapeutics is 1.33 times less risky than Evaxion Biotech. It trades about 0.04 of its potential returns per unit of risk. Evaxion Biotech AS is currently generating about -0.02 per unit of risk. If you would invest  261.00  in Eliem Therapeutics on September 3, 2024 and sell it today you would earn a total of  43.00  from holding Eliem Therapeutics or generate 16.48% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eliem Therapeutics  vs.  Evaxion Biotech AS

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Evaxion Biotech AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evaxion Biotech AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Eliem Therapeutics and Evaxion Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Evaxion Biotech

The main advantage of trading using opposite Eliem Therapeutics and Evaxion Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Evaxion Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evaxion Biotech will offset losses from the drop in Evaxion Biotech's long position.
The idea behind Eliem Therapeutics and Evaxion Biotech AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format